Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 3
1987 5
1988 1
1989 3
1990 8
1991 2
1992 2
1993 2
1995 5
1996 2
1997 5
1998 2
1999 2
2000 5
2001 4
2002 3
2003 3
2004 4
2005 3
2006 3
2007 4
2008 5
2009 11
2010 15
2011 12
2012 7
2013 11
2014 8
2015 5
2016 5
2017 1
2018 5
2019 7
2020 11
2021 6
2022 15
2023 10
2024 11
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Fong Y, et al. Clin Infect Dis. 2025 Feb 5;80(1):223-227. doi: 10.1093/cid/ciae465. Clin Infect Dis. 2025. PMID: 39325506 Free PMC article. Clinical Trial.
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience.
Capasso I, Perrone E, Duranti S, Giannarelli D, Nero C, Cordisco EL, Pomponi MG, Remondini L, Piermattei A, Valente M, Santoro A, Esposito G, Parisi G, Giuliano MC, Corrado M, Scambia G, Fanfani F. Capasso I, et al. Among authors: piermattei a. Eur J Cancer. 2025 May 2;220:115344. doi: 10.1016/j.ejca.2025.115344. Epub 2025 Mar 5. Eur J Cancer. 2025. PMID: 40058269 Free article.
POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort.
Nero C, Trozzi R, Persiani F, Rossi S, Mastrantoni L, Duranti S, Camarda F, Marino I, Giacò L, Pasciuto T, De Bonis M, Rinelli M, Perrone E, Giacomini F, Lorusso D, Piermattei A, Zannoni G, Fanfani F, Scambia G, Minucci A. Nero C, et al. Among authors: piermattei a. Cancer. 2025 Feb 1;131(3):e35731. doi: 10.1002/cncr.35731. Cancer. 2025. PMID: 39865420 Free PMC article.
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial.
Edupuganti S, Hurt CB, Stephenson KE, Huang Y, Paez CA, Yu C, Yen C, Hanscom B, He Z, Miner MD, Gamble T, Heptinstall J, Seaton KE, Domin E, Lin BC, McKee K, Doria-Rose N, Regenold S, Spiegel H, Anderson M, McClosky N, Zhang L, Piwowar-Manning E, Ackerman ME, Pensiero M, Dye BJ, Landovitz RJ, Mayer K, Siegel M, Sobieszczyk M, Walsh SR, Gama L, Barouch DH, Montefiori DC, Tomaras GD; HVTN 136/HPTN 092 Study Team. Edupuganti S, et al. Lancet HIV. 2025 Jan;12(1):e13-e25. doi: 10.1016/S2352-3018(24)00247-9. Epub 2024 Dec 10. Lancet HIV. 2025. PMID: 39667379 Clinical Trial.
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma.
Santoro A, Angelico G, Narducci N, Travaglino A, Piermattei A, Inzani F, Arciuolo D, Addante F, Urtueta BP, Tinnirello G, Scaglione G, D'Alessandris N, Valente M, Minucci A, Zannoni GF. Santoro A, et al. Among authors: piermattei a. Virchows Arch. 2025 Feb 14. doi: 10.1007/s00428-024-03972-9. Online ahead of print. Virchows Arch. 2025. PMID: 39948242
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer.
De Paolis E, Nero C, Micarelli E, Leoni G, Piermattei A, Trozzi R, Scarselli E, D'Alise AM, Giacò L, De Bonis M, Preziosi A, Daniele G, Piana D, Pasciuto T, Zannoni G, Minucci A, Scambia G, Urbani A, Fanfani F. De Paolis E, et al. Among authors: piermattei a. NPJ Precis Oncol. 2024 Dec 20;8(1):283. doi: 10.1038/s41698-024-00779-4. NPJ Precis Oncol. 2024. PMID: 39706858 Free PMC article.
Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study.
Bizzarri N, Arciuolo D, Certelli C, Pedone Anchora L, Gallotta V, Teodorico E, Carbone MV, Piermattei A, Fanfani F, Fagotti A, Ferrandina G, Zannoni GF, Scambia G, Querleu D. Bizzarri N, et al. Among authors: piermattei a. Cancers (Basel). 2023 Feb 9;15(4):1099. doi: 10.3390/cancers15041099. Cancers (Basel). 2023. PMID: 36831442 Free PMC article.
207 results